Pricing Strategies For Cell And Gene Therapy
Source: ZS Associates, Inc.
Today, fewer than 25% of eligible patients benefit from cell and gene therapies. Expanding the impact of these therapies must start early in their development as you plan your network strategy and design flexible contracts with payers and providers.
For therapies that challenge traditional payment options, we help design better outcome-based, risk sharing models while communicating their value to payers and providers. We help you build new partnerships to deliver the promise of curing more patients.
- Value-driven pricing and contracting: We’ll help you develop pricing strategies supported by qualitative and quantitative research methodologies that address both price-volume trade-offs and emotional reactions to price. State-of-the-art analytical techniques can help you with rapid decision-making in competitive contracting scenarios.
- Expanding beyond value: A coordinated communication plan goes beyond the superficial; You need to convey what your offering will help customers achieve. We can help you conduct benefits analyses to construct a compelling value story that illustrates how your offering meets customers’ unmet needs and delivers true value.
This website uses cookies to ensure you get the best experience on our website. Learn more